Cellosaurus NCI-H358 (CVCL_1559)

Cell line name NCI-H358
Synonyms H358; H-358; NCIH358
Accession CVCL_1559
Resource Identification Initiative To cite this cell line use: NCI-H358 (RRID:CVCL_1559)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: MD Anderson Cell Lines Project.
Doubling time: 38 hours (in RPMI 1640+10% FBS), 76 hours (in ACL-3), 60 hours (in ACL-3+BSA) (PubMed=3940644); 38 hours (ECACC).
Microsatellite instability: Stable (MSS) (Sanger).
Sequence variation: Heterozygous for KRAS p.Gly12Cys.
Omics: Deep exome analysis.
Omics: Deep phosphoproteome analysis.
Omics: Deep proteome analysis.
Omics: Deep RNAseq analysis.
Omics: DNA methylation analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Caution: We are not certain that NCI-H358 and NCI-H358M are identical.
Disease Bronchioloalveolar carcinoma (NCIt: C2923)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children: CVCL_JA53 (NCI-H358M)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): AddexBio; ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200

Markers:
AmelogeninX,Y
CSF1PO11,12
D13S3178,12
D16S53912,13
D18S5114
D21S1128,30
D3S135814,18
D5S81810,12
D7S82010,11
D8S117913,14
FGA20,21
Penta D10,13
Penta E18
TH016
TPOX8,9
vWA17
Web pages http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-368.html
http://tcpaportal.org/mclp/
Publications

PubMed=3940644
Brower M., Carney D.N., Oie H.K., Gazdar A.F., Minna J.D.
Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.
Cancer Res. 46:798-806(1986)

PubMed=2386953
Gazdar A.F., Linnoila R.I., Kurita Y., Oie H.K., Mulshine J.L., Clark J.C., Whitsett J.A.
Peripheral airway cell differentiation in human lung cancer cell lines.
Cancer Res. 50:5481-5487(1990)

PubMed=8806092; DOI=10.1002/jcb.240630505
Phelps R.M., Johnson B.E., Ihde D.C., Gazdar A.F., Carbone D.P., McClintock P.R., Linnoila R.I., Matthews M.J., Bunn P.A. Jr., Carney D.N., Minna J.D., Mulshine J.L.
NCI-Navy Medical Oncology Branch cell line data base.
J. Cell. Biochem. 63 Suppl. 24:32-91(1996)

PubMed=8806101; DOI=10.1002/jcb.240630514
Lokshin A., Levitt M.L.
Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines.
J. Cell. Biochem. 63 Suppl. 24:186-197(1996)

PubMed=9649128; DOI=10.1038/bjc.1998.361
Yi S., Chen J.-R., Viallet J., Schwall R.H., Nakamura T., Tsao M.-S.
Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.
Br. J. Cancer 77:2162-2170(1998)

PubMed=11030152; DOI=10.1038/sj.onc.1203815
Modi S., Kubo A., Oie H., Coxon A.B., Rehmatulla A., Kaye F.J.
Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Oncogene 19:4632-4639(2000)

PubMed=11369051; DOI=10.1016/S0165-4608(00)00363-0
Luk C., Tsao M.-S., Bayani J., Shepherd F., Squire J.A.
Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.
Cancer Genet. Cytogenet. 125:87-99(2001)

PubMed=19472407; DOI=10.1002/humu.21028
Blanco R., Iwakawa R., Tang M., Kohno T., Angulo B., Pio R., Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M.
A gene-alteration profile of human lung cancer cell lines.
Hum. Mutat. 30:1199-1206(2009)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=24135919; DOI=10.1038/ncomms3617
Balbin O.A., Prensner J.R., Sahu A., Yocum A., Shankar S., Malik R., Fermin D., Dhanasekaran S.M., Chandler B., Thomas D., Beer D.G., Cao X., Nesvizhskii A.I., Chinnaiyan A.M.
Reconstructing targetable pathways in lung cancer by integrating diverse omics data.
Nat. Commun. 4:2617-2617(2013)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z., Liu H., Degenhardt J., Mayba O., Gnad F., Liu J., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

Cross-references
Cell line collections AddexBio; C0016016/4968
ATCC; CRL-5807
ECACC; 95111733
KCLB; 25807
KCLB; 90358
NCI-DTP; NCI-H358
Cell line databases/resources CLDB; cl3656
CCLE; NCIH358_LUNG
CCRID; 3131C0001000700151
Cosmic-CLP; 908465
GDSC; 908465
IGRhCellID; NCIH358
LINCS_LDP; LCL-1671
Ontologies BTO; BTO:0002835
CLO; CLO_0008085
EFO; EFO_0002291
Biological sample resources BioSample; SAMN03471313
Chemistry resources ChEMBL-Cells; CHEMBL3307543
ChEMBL-Targets; CHEMBL614135
Gene expression databases GEO; GSM206491
GEO; GSM253398
GEO; GSM274731
GEO; GSM274732
GEO; GSM385520
GEO; GSM385531
GEO; GSM434257
GEO; GSM513937
GEO; GSM514321
GEO; GSM784251
GEO; GSM794285
GEO; GSM827468
GEO; GSM844648
GEO; GSM887427
GEO; GSM888507
GEO; GSM1374744
GEO; GSM1670241
Polymorphism and mutation databases Cosmic; 722039
Cosmic; 724875
Cosmic; 877106
Cosmic; 903573
Cosmic; 908465
Cosmic; 910563
Cosmic; 914944
Cosmic; 929970
Cosmic; 934545
Cosmic; 980963
Cosmic; 1004699
Cosmic; 1028934
Cosmic; 1032435
Cosmic; 1052333
Cosmic; 1146915
Cosmic; 1219075
Cosmic; 1239902
Cosmic; 1600603
Cosmic; 1741780
Cosmic; 1802307
Cosmic; 1870273
Cosmic; 1995575
Cosmic; 2042868
Cosmic; 2630418